Stocks to Watch: Horizon Pharma Inc (NASDAQ:HZNP), Avanir Pharmaceuticals (NASDAQ:AVNR), Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Supernus Pharmaceuticals (NASDAQ:SUPN)

Specialist pharmaceutical company Horizon Pharma Inc (NASDAQ:HZNP) revealed on Thursday the receipt of Notice of Allowance for US Patent Application 13/713,528 entitled “Delayed-Release Tablet with Defined Core Geometry” that covers its US approved product RAYOS. Horizon Pharma Inc (NASDAQ:HZNP) stock performance was -7.89% in last session and finished the day at $12.02. Traded volume was 3.88million shares in the last session and the average volume … Continue reading Stocks to Watch: Horizon Pharma Inc (NASDAQ:HZNP), Avanir Pharmaceuticals (NASDAQ:AVNR), Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Supernus Pharmaceuticals (NASDAQ:SUPN)

Chris Lewis04/1404/14

Drugs Generic: Neurocrine Biosciences (NASDAQ:NBIX), The Medicines Company (NASDAQ:MDCO), Avanir Pharmaceuticals (NASDAQ:AVNR), Horizon Pharma (NASDAQ:HZNP)

Investors eyeing a purchase of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock, but tentative about paying the going market price of $14.27/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $11 strike, which has a bid at the time of this writing of $1.65. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock performance … Continue reading Drugs Generic: Neurocrine Biosciences (NASDAQ:NBIX), The Medicines Company (NASDAQ:MDCO), Avanir Pharmaceuticals (NASDAQ:AVNR), Horizon Pharma (NASDAQ:HZNP)

Richard Atkins04/0904/09

Investors Watch List: Schlumberger Limited (NYSE:SLB), CafePress Inc. (NASDAQ:PRSS), Village Super Market Inc. (NASDAQ:VLGEA), Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR), Xylem Inc. (NYSE:XYL)

Zacks reissued their neutral rating on shares of Schlumberger Limited. (NYSE:SLB) in a research report sent to investors on Monday morning. The firm currently has a $104.00 price target on the stock. Schlumberger Limited (NYSE:SLB) belongs to Basic Materials sector. Its net profit margin is 14.20% and weekly performance is -2.31%. On last trading day company shares ended up $92.81. Schlumberger Limited (NYSE:SLB) distance from … Continue reading Investors Watch List: Schlumberger Limited (NYSE:SLB), CafePress Inc. (NASDAQ:PRSS), Village Super Market Inc. (NASDAQ:VLGEA), Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR), Xylem Inc. (NYSE:XYL)

Kevin Long11/28

Today’s Stocks: Rogers Corporation (NYSE:ROG), Avanir Pharmaceuticals (NASDAQ:AVNR), AngloGold (NYSE:AU), ICICI Bank Ltd. (NYSE:IBN), Yelp, Inc. (NYSE:YELP)

One such stock that you may want to consider dropping is Rogers Corporation (NYSE:ROG) which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. A Zacks Rank #5 (Strong Sell) further confirms weakness in ROG. Rogers Corporation (NYSE:ROG) belongs to Technology sector. Its net profit margin is … Continue reading Today’s Stocks: Rogers Corporation (NYSE:ROG), Avanir Pharmaceuticals (NASDAQ:AVNR), AngloGold (NYSE:AU), ICICI Bank Ltd. (NYSE:IBN), Yelp, Inc. (NYSE:YELP)

Jayne Crisman08/0408/04

Trending Stocks : AT&T (NYSE:T), Sprint Corporation (NYSE:S), Avanir Pharmaceuticals (NASDAQ:AVNR), Booz Allen Hamilton (NYSE:BAH), Syngenta (NYSE:SYT)

Zacks reissued their outperform rating on shares of AT&T (NYSE:T) in a research report released on Wednesday morning. Zacks currently has a $12.00 price objective on the stock. AT&T, Inc. (NYSE:T)’s stock on 31 July traded at beginning with a price of $36.05 and when day-trade ended the stock finally fell -2.12% to end at $35.59. AT&T, Inc. (NYSE:T)’s showed weekly performance of 0.25%. Sprint … Continue reading Trending Stocks : AT&T (NYSE:T), Sprint Corporation (NYSE:S), Avanir Pharmaceuticals (NASDAQ:AVNR), Booz Allen Hamilton (NYSE:BAH), Syngenta (NYSE:SYT)

Mark Doerr08/01

FB Nasdaq FB Facebook

Healthcare Gainers: BioScrip Inc (NASDAQ:BIOS), NPS Pharmaceuticals (NASDAQ:NPSP), RadNet Inc. (NASDAQ:RDNT), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

BioScrip Inc (NASDAQ:BIOS), on May 8, 2014 announced 2014 first quarter financial results. First quarter revenue from continuing operations was $239.6 million and the net loss from continuing operations was $25.4 million, or $0.37 per basic and diluted share. Non-GAAP adjusted loss from continuing operations per basic and diluted share was $0.13.BioScrip Inc (NASDAQ:BIOS) stock performance was 17.08% in last session and finished the day … Continue reading Healthcare Gainers: BioScrip Inc (NASDAQ:BIOS), NPS Pharmaceuticals (NASDAQ:NPSP), RadNet Inc. (NASDAQ:RDNT), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

Richard Atkins05/12